Background: Psoriasis is a chronic and inflammatory disease that impairs quality of life and causes psychological symptoms. Despite the high prevalence of psoriasis in pediatric patients, studies investigating the impact of psoriasis in the quality of life of children, adolescents and families are sparse. oBjective: To investigate the impact of psoriasis in the quality of life of children and adolescents with psoriasis and their families and to determine depression and anxiety levels of the patients. Methods: A total of 58 patients with psoriasis aged 7-18 years (median age: 11) and a family member of each patient were included in the study. Children's Dermatology Life Quality Index (CDLQI), Family Dermatology Life Quality Index (FDLQI), Children's Depression Inventory (CDI) and State-Trait Anxiety Inventory for Children (STAIC) were used in the study. results: The median PASI score of the patients included in the study was 1.8. The median CDLQI and FDLQI scores in the study groups were 5 and 10, respectively. The median CDI score, STAIC-state and STAIC-trait scores of the patients were 6, 28 and 32.5, respectively. study liMitations: Lack of a control group and patient assessment of disease severity. Relatively mild disease severity of the subjects. conclusions: Psoriasis has a negative impact in the quality of life of children, adolescents and their families, even in the presence of mild disease. Considering that impairment in quality of life may be associated with psychosocial morbidity, a combined approach with medical therapy, family counseling and quality of life assessment may be beneficial in this patient group.
INTRODUCTION
Psoriasis is a chronic, inflammatory skin disorder affecting approximately 2% of the population. In almost one third of the patients, the onset of psoriasis is within the first two decades of life. 1 In addition to signs and symptoms related to cutaneous lesions, psoriasis may cause significant impairment in quality of life and psychological symptoms. 2 However, despite the high prevalence of psoriasis in childhood, studies investigating the impact of psoriasis in the quality of life of patients and families and psoriasis-related psychosocial morbidity are sparse. Assessment of quality of life in this patient group and their families may be particularly important for the psychological well-being of the children and adolescents. In the long run, such an awareness on the impact of psoriasis in the quality of life of the child and the family may lead to an integration of psychological approach and medical treatment strategies. 3 Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study The CDI is a self-rated, 27-item questionnaire providing a score of 0 to 54, higher scores suggesting more severe depressive symptoms. A cut-off score of 16 has been recommended for CDI. 7 The STAIC consists of 40 items and two parts assessing the levels of state and trait anxiety. 8 Scores range between 20 and 60.
Higher scores indicate higher levels of anxiety. The validity and reliability of the Turkish versions of indices have been established.
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Statistical Analysis
The statistical analysis was done using the Statistical Pack- 
RESULTS
A total of 58 patients (32 females, 26 males) with psoriasis were included in the study. The median age of the patients was 11 (Table 1) . The most commonly used treatments prior to the interview were topical corticosteroids (77.6%), phototherapy (10.3%) and acitretin (6.9%).
Primary caregiver who filled the FDLQI was mother, father and grandmother in 84.5%, 13.8% and 1.7% of the patients, respectively.
Socioeconomic status of the patients' families according to SSI were as follows; A (6.9%), B (15.5%), C1 (39.7%), C2 (36.2%) and
The median CDLQI score of the patients was 5(2-8.25). According to CDLQI scores, 21 of the patients (36.2%) have reported a moderate or more effect of psoriasis on their quality-of-life ( Table 2 ).
The median FDLQI score of the caregivers was 10(6.75-15.25) ( Table 3 ).
The median CDI, STAIC-state and STAIC-trait scores of the patients were shown in table 3. Only four patients (6.8%) had scores higher than 16, the cut-off value in CDI.
When patients were grouped according to their age (<12 (n=32) vs >12 (n=26)), no significant difference was found in terms of median PASI, duration of disease, CDLQI, FDLQI, CDI and STA- When patients were grouped according to CDLQI scores as "small or no effect" (CDLQI score ≤ 6, n=38) and "moderate or more effect" (CDLQI score ≥ 7, n=22), PASI, CDI and STAIC-trait scores were significantly higher in the latter group (p=0.018, p=0.004, and p=0.029, respectively).
DISCUSSION
The results of our study indicate that childhood psoriasis causes impairment in quality of life in patients and their families. This will probably lead to a better family functioning and a better care for their children.
Negative impact of psoriasis on quality of life and psychosocial development may result in psychological maladjustment in several areas. Previous studies in adult and pediatric psoriasis patients have reported a tendency towards high levels of anxiety, depression, stigmatization and low self-esteem. 13, 18, 22 However, it has also been documented that not all patients with chronic disorders appeared maladjusted. 23 Psychological adjustment relies on many factors, of which vulnerability and resilience are also important components. In our study the severity of depressive symptoms tended to be low, whereas, adolescent patients in the sample had higher levels of anxiety. For many chronically ill children, anxiety about being physically different from their peers is a common concern. 24 It becomes even a major issue especially in adolescence. That is, when sense of belonging to a peer group is one of the challenges, and consequently physical appearance becomes an important focus.
Therefore, any skin disease may cause a considerable level of psychological distress for the young in this particular age group. 5 Another finding of the study was that, the group with high impact on quality of life had higher levels of anxiety and depressive symptoms. It can be assumed that there is a bi-directional relation between the patients' sense of quality of life and emotional symptoms. This finding is highly correlated with previous studies emphasizing that as the impact on quality of life becomes greater, the depressive and anxiety symptoms become more prominent. 25 Although it is not possible to draw definite conclusions due to our study's cross-sectional design, it might be speculated that impairment of quality of life along with the possible stigmatization and social isolation may cause increased levels of psychosocial morbidities in patients with psoriasis.
In our study CDLQI scores were positively correlated with severity and duration of psoriasis, anxiety and depression scores.
Considering that overall severity in our study group was mild, early recognition and assessment of quality of life impairment in patients with psoriasis may prevent them having impaired daily functioning and development of psychiatric morbidities.
In the present study, there was no significant correlation between FDLQI and CDLQI scores. This result indicates that psoriasis may affect the quality of life of families regardless of its effect in the quality of life of patients with psoriasis. Therefore, in addition to patients' quality of life, family quality of life should also be carefully assessed, so that families can provide better care to their children.
Our study is limited by the mild nature of the disease in our study population. Even though an impairment in quality of life was detected, it would be interesting to see the level of quality life impairment between mild and severe disease groups. Other limitations of our study are lack of an age-matched control population and patient assessment of their disease severity. 
CONCLUSION
